Skip to main content
Equibles
MGTX logo

MGTX · MeiraGTx Holdings plc · Metrics

Track MGTX — free

Use MGTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MGTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.86 -0.11 (-1.10%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$946.98M
Shares
96.04M
Volume · Oct 21 635.59K Avg daily vol (3M) 789.74K

MGTX metrics

84 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.86
Market cap
$946.98M

Price action

20 metrics
Price change (1W)
+4.8%
Price change (30D)
-20.2%
Price change (3M)
-18.9%
Price change (6M)
-1.7%
Price change (YTD)
+24.0%
Price change (1Y)
+6.5%
Trailing year
Price change (5Y)
-53.0%
52-week high
$14.97
52-week low
$6.99
Change from 52-week high
-34.1%
Change from 52-week low
+41.1%
Annualized volatility
57.8%
Annualized volatility (3M)
47.4%
Beta
1.7
RSI (14D)
37.7
Price vs SMA 50
-19.9%
Price vs SMA 200
-3.7%
Avg volume (3M)
789,736
Relative volume
0.8
Average dollar volume
$9.60M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
96.04M

Valuation

12 metrics
P / E (TTM)
13.9
Trailing earnings · reciprocal yield 7.2%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.4×
reciprocal yield 42.0%
P / book
4.4
reciprocal yield 22.8%
FCF yield
1.1%
TTM · current market cap
Buyback yield
—
P / FCF
90.5
reciprocal yield 1.1%
P / operating cash flow
69.2
reciprocal yield 1.4%
Earnings yield
8.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-04-16

Profitability

9 metrics
Gross margin
—
Operating margin
46.3%
Trailing 12 months
Net margin
19.9%
Gross profit (TTM)
—
Operating profit (TTM)
$184.03M
Net income (TTM)
$78.98M
Trailing 12 months
Diluted EPS (TTM)
$0.71
FCF margin
2.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$4.36
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$1.86
EBITDA per diluted share (TTM)
$2.01
Net income per diluted share (TTM)
$0.71
Operating cash flow per diluted share (TTM)
$0.23
Free cash flow per diluted share (TTM)
$0.19
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$1.79
Stock compensation per diluted share (TTM)
$0.23
Book value per share
$-0.07

Growth

11 metrics
Revenue growth YoY
+8,608.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$397.50M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+16.4%
Year over year · more shares
Revenue CAGR (3Y)
+72.3%
Revenue CAGR (5Y)
+39.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
36.6%
Return on assets
19.9%
Debt / equity
—
Current ratio
3.8
EBITDA (TTM)
$196.13M
Free cash flow (TTM)
$10.47M
Quick ratio
—
Interest coverage
14.7
Net debt / EBITDA
-0.7
Return on invested capital
—
Trailing 12 months
Net cash
$143.17M
Latest balance sheet
Cash & equivalents
$143.17M
Total assets
$396.45M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.69M
Capital expenditures (TTM)
$3.22M
R&D (TTM)
$153.16M
SG&A (TTM)
—
Stock compensation (TTM)
$18.99M
R&D / revenue
38.5%
Stock compensation / revenue
4.8%

Ownership (13F)

9 metrics
13F filers
158
13F filer change QoQ
+25
Institutional ownership
82.6%
Conviction holders (share of 13F filers)
3.8%
Crowding (high-turnover and private-fund holders)
47.5%
Private-fund adviser ownership
45.4%
Active holders' share change QoQ
+14.3%
Holder tenure
13.3
Price vs estimated holder cost
+62.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.7%

Short interest

3 metrics
Short interest
6.2%
Latest settlement · 5.0 days to cover
Days to cover
5.0d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.71M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1735438 CUSIP G59665102 13F (30d) 16 filings 16 filers Visit website Investor relations